Display Settings:

Format

Send to:

Choose Destination

    Pediatrics. 2001 Aug;108(2):468-70.

    Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.

    El Hassan NO, Chess PR, Huysman MW, Merkus PJ, de Jongste JC.

    Department of Pediatrics, Division of Neonatology, University of Rochester Medical Center, Rochester, NY 14642, USA. nahed_elhassan@urmc.rochester.edu

    Excessive or thick pulmonary secretions are a common clinical challenge in the neonatal population. Mucus accumulation can cause many life-threatening complications, including plugging of the endotracheal tube and increasing the risk of pulmonary infections. We report 3 premature neonates who had critical pulmonary collapse secondary to mucous plugging. Different conventional methods to liquefy mucus and facilitate removal of secretions were exhausted to no avail. The rescue use of DNase was effective in reestablishing airway patency. Thus, this drug could be a valuable tool in treating atelectasis and mucus-plugging in mechanically ventilated, premature neonates.

    PMID: 11483817 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Dornase Alfa (Pulmozyme®)

      Dornase alfa is used to reduce the number of lung infections and to improve lung function in patients with cystic fibrosis. It breaks down the thick secretions in the airways, allowing air to flow better and preventing b...